Low-Density lipoprotein values estimated by friedewald equation are affected by diabetes control

Mailing Address: Gustavo Neves de Araujo Ramiro Barcelos 2350, Independência. Postal Code: 90035-003, Porto Alegre, RS – Brazil E-mail: gustavon.araujo@gmail.com Low-Density Lipoprotein Values Estimated by Friedewald Equation are Affected by Diabetes Control Pedro Lima Vieira, Gustavo Neves Araújo, Guilherme Heyden Telo, Luis Felipe Silva Smidt, Mariana Ferreira Jost, Mariana Vargas Furtado, Emilio Hideyuki Moriguchi, Carisi Anne Polanczyk Hospital de Clinicas de Porto Alegre and Universidade Federal do Rio Grande do Sul, Porto Alegre, RS – Brazil

[1]  P. Joshi,et al.  Friedewald-estimated versus directly measured low-density lipoprotein cholesterol and treatment implications. , 2013, Journal of the American College of Cardiology.

[2]  AndrewJ. S. Coats.  MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial , 2002, The Lancet.

[3]  D. Altman,et al.  Measuring agreement in method comparison studies , 1999, Statistical methods in medical research.

[4]  D. Levy,et al.  Prediction of coronary heart disease using risk factor categories. , 1998, Circulation.

[5]  S. MacMahon,et al.  Use of the Friedewald formula to estimate LDL-cholesterol in patients with chronic renal failure on dialysis. , 1997, Clinical chemistry.

[6]  M. Sentí,et al.  Calculated Low-Density Lipoprotein Cholesterol Should Not Be Used for Management of Lipoprotein Abnormalities in Patients With Diabetes Mellitus , 1993, Diabetes Care.

[7]  P. Wilson,et al.  Serum cholesterol as a prognostic factor after myocardial infarction: the Framingham Study. , 1991, Annals of internal medicine.

[8]  B. Rifkind,et al.  The value of lowering cholesterol after myocardial infarction. , 1990, The New England journal of medicine.

[9]  J Pekkanen,et al.  Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease. , 1990, The New England journal of medicine.

[10]  G. Reaven.  Abnormal lipoprotein metabolism in non-insulin-dependent diabetes mellitus. Pathogenesis and treatment. , 1987, The American journal of medicine.

[11]  B. Howard,et al.  Lipoprotein metabolism in diabetes mellitus. , 1987, Journal of lipid research.

[12]  J. Neaton,et al.  Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). , 1986, JAMA.

[13]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.

[14]  I. Jialal,et al.  A more valid measurement of low-density lipoprotein cholesterol in diabetic patients. , 1997, The American journal of medicine.